As of 2025-01-16, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 16.3x | 15.8x |
| Forward P/E multiples | 14.8x - 19.8x | 15.5x |
| Fair Price | (2.33) - (2.74) | (2.55) |
| Upside | -107.4% - -108.8% | -108.2% |
| Date | EV/EBITDA |